Lsv Asset Management Amgen Inc Transaction History

Lsv Asset Management

$45.6 Billion
Q2 2024

A detailed history of Lsv Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Lsv Asset Management holds 766,190 shares of AMGN stock, worth $242 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

766,190

Previous 1,360,114 43.67%

Holding current value

$242 Million

Previous $387 Million 38.09%

% of portfolio

0.52%

Previous 0.8%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $156 Million - $190 Million	-593,924 Reduced 43.67%	766,190 $239 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $126 Million - $153 Million	-470,087 Reduced 25.68%	1,360,114 $387 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $26.3 Million - $29.6 Million	-102,747 Reduced 5.32%	1,830,201 $527 Million
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $21.4 Million - $26.6 Million	-98,070 Reduced 4.83%	1,932,948 $519 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $18.1 Million - $21.4 Million	-84,300 Reduced 3.99%	2,031,018 $451 Million
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $18.4 Million - $22.4 Million	-81,438 Reduced 3.71%	2,115,318 $511 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $27.9 Million - $35.5 Million	-121,830 Reduced 5.25%	2,196,756 $577 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $4.7 Million - $5.3 Million	-20,930 Reduced 0.89%	2,318,586 $523 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $13.7 Million - $15.2 Million	-59,376 Reduced 2.48%	2,339,516 $569 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $12.6 Million - $14 Million	57,674 Added 2.46%	2,398,892 $580 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $6.01 Million - $6.87 Million	-30,200 Reduced 1.27%	2,341,218 $527 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $4.29 Million - $5.03 Million	-20,225 Reduced 0.85%	2,371,418 $504 Million
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $5.16 Million - $5.73 Million	-22,110 Reduced 0.92%	2,391,643 $583 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $31.1 Million - $36.3 Million	-140,258 Reduced 5.49%	2,413,753 $601 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $38.4 Million - $45.7 Million	-177,529 Reduced 6.5%	2,554,011 $587 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $29.5 Million - $32.8 Million	-125,599 Reduced 4.4%	2,731,540 $694 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $93.1 Million - $114 Million	-470,657 Reduced 14.14%	2,857,139 $674 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $31 Million - $41.1 Million	-170,131 Reduced 4.86%	3,327,796 $675 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $31.9 Million - $40.9 Million	-168,357 Reduced 4.59%	3,497,927 $843 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $25.4 Million - $30.4 Million	-145,890 Reduced 3.83%	3,666,284 $709 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $16.2 Million - $19 Million	-97,231 Reduced 2.49%	3,812,174 $703 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $20.8 Million - $23.5 Million	-115,224 Reduced 2.86%	3,909,405 $743 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $12 Million - $14.1 Million	-67,474 Reduced 1.65%	4,024,629 $783 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $12.1 Million - $13.7 Million	-65,546 Reduced 1.58%	4,092,103 $848 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $21.4 Million - $24 Million	128,865 Added 3.2%	4,157,649 $767 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $36.3 Million - $42.4 Million	214,013 Added 5.61%	4,028,784 $687 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $39.6 Million - $44.2 Million	234,461 Added 6.55%	3,814,771 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $599 Million - $684 Million	3,580,310	3,580,310 $668 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Amgen Inc Transaction History